MeiraGTx Holdings (MGTX) Operating Income (2017 - 2025)
MeiraGTx Holdings (MGTX) posted Operating Income of $18.2 million for Q4 2025, up 139.61% on a QoQ basis from -$46.1 million in Q3 2025, and up 157.92% year-over-year from $7.1 million in Q4 2024.
MeiraGTx Holdings (MGTX) Operating Income (2017 - 2025) Analysis & Trends
MeiraGTx Holdings' Operating Income history runs 9 years deep, the most recent figure standing at $18.2 million for Q4 2025.
- Quarterly Operating Income rose 157.92% year-over-year to $18.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$106.6 million (up 35.87% YoY) and the FY2025 annual result came in at -$114.2 million, up 30.46% from the prior year.
- Operating Income was $18.2 million for Q4 2025 at MeiraGTx Holdings, up from -$46.1 million in the prior quarter.
- Across five years, Operating Income topped out at $18.2 million in Q4 2025 and bottomed at -$48.6 million in Q2 2024.
- A 5-year average of -$27.3 million and a median of -$30.1 million in 2023 frame the typical range for Operating Income.
- Annual changes were most pronounced in 2024 — Operating Income tumbled 439.33% — and 2025, when it soared 157.92%.
- MeiraGTx Holdings' Operating Income stood at -$7.7 million in 2021, then tumbled by 433.88% to -$41.1 million in 2022, then jumped by 122.6% to $9.3 million in 2023, then tumbled by 439.33% to -$31.5 million in 2024, then surged by 157.92% to $18.2 million in 2025.
- Business Quant data shows MGTX's Operating Income at $18.2 million in Q4 2025, -$46.1 million in Q3 2025, and -$38.8 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 18.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18.24 Mn |
| Sep 30, 2025 | -46.05 Mn |
| Jun 30, 2025 | -38.80 Mn |
| Mar 31, 2025 | -39.98 Mn |
| Dec 31, 2024 | -31.49 Mn |
| Sep 30, 2024 | -39.33 Mn |
| Jun 30, 2024 | -48.62 Mn |
| Mar 31, 2024 | -46.77 Mn |
| Dec 31, 2023 | 9.28 Mn |
| Sep 30, 2023 | -32.76 Mn |
| Jun 30, 2023 | -28.79 Mn |
| Mar 31, 2023 | -31.76 Mn |
| Dec 31, 2022 | -41.06 Mn |
| Sep 30, 2022 | -22.81 Mn |
| Jun 30, 2022 | -23.76 Mn |
| Mar 31, 2022 | -28.73 Mn |
| Dec 31, 2021 | -7.69 Mn |
| Sep 30, 2021 | -22.55 Mn |
| Jun 30, 2021 | -20.48 Mn |
| Mar 31, 2021 | -22.03 Mn |